𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bone morphogenetic protein-4 enhances vascular endothelial growth factor secretion by human retinal pigment epithelial cells

✍ Scribed by Rhonda R. Vogt; Richard Unda; Lee-Chuan C. Yeh; Eileen K. Vidro; John C. Lee; Andrew T. Tsin


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
143 KB
Volume
98
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Retinal pigment epithelial (RPE) cells secrete vascular endothelial growth factor (VEGF), a cytokine known to promote angiogenesis. Results from RNase protection assays (RPAs) show that RPE from non‐diabetic human donors and from adult retinal pigment epithelium‐19 (ARPE‐19) cells expressed significant bone morphogenetic protein‐4 (BMP‐4) message. In addition, ARPE‐19 cells cultured in high glucose (25 mM), compared to those in physiological glucose (5.5 mM) released significantly more BMP‐4 into the conditioned media (CM). However, the effect of BMP‐4 on the release of VEGF by ARPE‐19 cells has not been studied. Accordingly, ARPE‐19 cells were treated with BMP‐4 to determine VEGF secretion. BMP‐4 and VEGF levels in the CM and cell lysates were measured by enzyme‐linked immunosorbent assay (ELISA). Cells treated with exogenous BMP‐4 had higher VEGF in the CM and this treatment effect was dose‐ and time‐dependent, while cell lysates had low levels of VEGF. Addition of cycloheximide (CHX) or actinomycin‐D (ACT) significantly reduced VEGF secretion from cells treated with BMP‐4, suggesting that the BMP‐4‐induced secretion of VEGF requires new RNA and protein synthesis. Our results suggest that BMP‐4 may play a role in the regulation of ocular angiogenesis associated with diabetic retinopathy (DR) by stimulating VEGF release from RPE cells. J. Cell. Biochem. 98: 1196–1202, 2006. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Transforming growth factor-β induces exp
✍ Chandrasekharam N. Nagineni; William Samuel; Sahrudaya Nagineni; Komanduri Pardh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB 👁 1 views

## Abstract Vascular endothelial growth factor (VEGF) is a major agent in choroidal and retinal neovascularization, events associated with age‐related macular degeneration (AMD) and diabetic retinopathy. Retinal pigment epithelium (RPE), strategically located between retina and choroid, plays a cri

Regulation of insulin-like growth factor
✍ Eva L. Feldman; Ann E. Randolph 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 859 KB

## Abstract Cultured human retinal pigment epithelial cells (RPE) secrete insulin‐like growth factor binding proteins (IGFBPs), a family of polypeptides which modulate the actions of the insulin‐like growth factors. RPE cells secrete two IGFBPs with Mr estimates of 34,000 and 46,000, respectively.

Up-regulation of bone morphogenetic prot
✍ Weerachai Singhatanadgit; Vehid Salih; Irwin Olsen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 1 views

## Abstract Bone morphogenetic proteins (BMP) stimulate osteoblast differentiation by signal transduction via three BMP receptors (BMPR‐IA, ‐IB, and ‐II). Several growth factors, including transforming growth factor‐β1 (TGF‐β1), fibroblast growth factor‐2 (FGF‐2) and platelet‐derived growth factor‐

Decreased expression of insulin-like gro
✍ William Samuel; R. Krishnan Kutty; Camasamudram Vijayasarathy; Iranzu Pascual; T 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB 👁 2 views

## Abstract Insulin‐like growth factor (IGF)‐binding protein‐5 (IGFBP5), an important member of the IGF axis involved in regulating cell growth and differentiation, acts by modulating IGF signaling and also by IGF‐independent mechanisms. We identified IGFBP5 by microarray analysis as a gene differe